Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Cell reports

Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN.
PMID: 28658632
Cell Rep. 2017 Jun 27;19(13):2878-2880. doi: 10.1016/j.celrep.2017.06.008.

No abstract available.

Cite
Farshidfar F, Zheng S, Gingras MC, et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017;19(13):2878-2880doi: 10.1016/j.celrep.2017.06.008.
Farshidfar, F., Zheng, S., Gingras, M. C., Newton, Y., Shih, J., Robertson, A. G., Hinoue, T., Hoadley, K. A., Gibb, E. A., Roszik, J., Covington, K. R., Wu, C. C., Shinbrot, E., Stransky, N., Hegde, A., Yang, J. D., Reznik, E., Sadeghi, S., Pedamallu, C. S., Ojesina, A. I., Hess, J. M., Auman, J. T., Rhie, S. K., Bowlby, R., Borad, M. J., Zhu, A. X., Stuart, J. M., Sander, C., Akbani, R., Cherniack, A. D., Deshpande, V., Mounajjed, T., Foo, W. C., Torbenson, M. S., Kleiner, D. E., Laird, P. W., Wheeler, D. A., McRee, A. J., Bathe, O. F., Andersen, J. B., Bardeesy, N., Roberts, L. R., & Kwong, L. N. (2017). Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell reports, 19(13), 2878-2880. https://doi.org/10.1016/j.celrep.2017.06.008
Farshidfar, Farshad, et al. "Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles." Cell reports vol. 19,13 (2017): 2878-2880. doi: https://doi.org/10.1016/j.celrep.2017.06.008
Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 Jun 27;19(13):2878-2880. doi: 10.1016/j.celrep.2017.06.008. PMID: 28658632; PMCID: PMC6141445.
Copy Download .nbib Format: NLM
Disordering kinetics in surface overlayers.

Physical review. B, Condensed matter

Jesina A, Tringides MC.
PMID: 10008667
Phys Rev B Condens Matter. 1993 Jul 15;48(4):2694-2698. doi: 10.1103/physrevb.48.2694.

No abstract available.

Cite
Jesina A, Tringides MC. Disordering kinetics in surface overlayers. Phys Rev B Condens Matter. 1993;48(4):2694-2698doi: 10.1103/physrevb.48.2694.
Jesina, A., & Tringides, M. C. (1993). Disordering kinetics in surface overlayers. Physical review. B, Condensed matter, 48(4), 2694-2698. https://doi.org/10.1103/physrevb.48.2694
Jesina, and Tringides. "Disordering kinetics in surface overlayers." Physical review. B, Condensed matter vol. 48,4 (1993): 2694-2698. doi: https://doi.org/10.1103/physrevb.48.2694
Jesina A, Tringides MC. Disordering kinetics in surface overlayers. Phys Rev B Condens Matter. 1993 Jul 15;48(4):2694-2698. doi: 10.1103/physrevb.48.2694. PMID: 10008667.
Copy Download .nbib Format: NLM
Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.

Cancers

Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI.
PMID: 34572780
Cancers (Basel). 2021 Sep 10;13(18). doi: 10.3390/cancers13184551.

Cervical cancer tumors with undetectable HPV (HPV

Cite
Ruiz FJ, Sundaresan A, Zhang J, et al. Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas. Cancers (Basel). 2021;13(18)doi: 10.3390/cancers13184551.
Ruiz, F. J., Sundaresan, A., Zhang, J., Pedamallu, C. S., Halle, M. K., Srinivasasainagendra, V., Zhang, J., Muhammad, N., Stanley, J., Markovina, S., Tiwari, H. K., Grigsby, P. W., Krakstad, C., Schwarz, J. K., & Ojesina, A. I. (2021). Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas. Cancers, 13(18), . https://doi.org/10.3390/cancers13184551
Ruiz, Fiona J, et al. "Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas." Cancers vol. 13,18 (2021). doi: https://doi.org/10.3390/cancers13184551
Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI. Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas. Cancers (Basel). 2021 Sep 10;13(18). doi: 10.3390/cancers13184551. PMID: 34572780; PMCID: PMC8467954.
Copy Download .nbib Format: NLM
Culture and Madness.

Mental health (London)

Ojesina JO.
PMID: 28908705
Ment Health (Lond). 1965 Aug;24(4):172-173.

No abstract available.

Cite
Ojesina JO. Culture and Madness. Ment Health (Lond). 1965;24(4):172-173
Ojesina, J. O. (1965). Culture and Madness. Mental health (London), 24(4), 172-173.
Ojesina, J Ola. "Culture and Madness." Mental health (London) vol. 24,4 (1965): 172-173.
Ojesina JO. Culture and Madness. Ment Health (Lond). 1965 Aug;24(4):172-173. PMID: 28908705; PMCID: PMC5085490.
Copy Download .nbib Format: NLM
Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero.

Neurotoxicology and teratology

Olajide OJ, Alliy ZO, Ojo DO, Osinubi OO, Bello SO, Ibrahim FE, Adukwu FO, Abikoye TO, Gbadamosi IT, Mutholib NY, Bamisi O, Ajiboye OJ, Okesina AA, Alli-Oluwafuyi A, Oyewole AL, Nafiu AB, Akinola O.
PMID: 33845156
Neurotoxicol Teratol. 2021 Jul-Aug;86:106982. doi: 10.1016/j.ntt.2021.106982. Epub 2021 Apr 16.

Despite reports that quinoline antimalarials including chloroquine (Chq) exhibit idiosyncratic neuropsychiatric effects even at low doses, the drug continues to be in widespread use during pregnancy. Surprisingly, very few studies have examined the potential neurotoxic action of Chq exposure...

Cite
Olajide OJ, Alliy ZO, Ojo DO, et al. Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero. Neurotoxicol Teratol. 2021;86:106982doi: 10.1016/j.ntt.2021.106982.
Olajide, O. J., Alliy, Z. O., Ojo, D. O., Osinubi, O. O., Bello, S. O., Ibrahim, F. E., Adukwu, F. O., Abikoye, T. O., Gbadamosi, I. T., Mutholib, N. Y., Bamisi, O., Ajiboye, O. J., Okesina, A. A., Alli-Oluwafuyi, A., Oyewole, A. L., Nafiu, A. B., & Akinola, O. (2021). Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero. Neurotoxicology and teratology, 86106982. https://doi.org/10.1016/j.ntt.2021.106982
Olajide, Olayemi Joseph, et al. "Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero." Neurotoxicology and teratology vol. 86 (2021): 106982. doi: https://doi.org/10.1016/j.ntt.2021.106982
Olajide OJ, Alliy ZO, Ojo DO, Osinubi OO, Bello SO, Ibrahim FE, Adukwu FO, Abikoye TO, Gbadamosi IT, Mutholib NY, Bamisi O, Ajiboye OJ, Okesina AA, Alli-Oluwafuyi A, Oyewole AL, Nafiu AB, Akinola O. Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero. Neurotoxicol Teratol. 2021 Jul-Aug;86:106982. doi: 10.1016/j.ntt.2021.106982. Epub 2021 Apr 16. PMID: 33845156.
Copy Download .nbib Format: NLM
Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.

Journal of pediatric hematology/oncology

Galadanci NA, Sohail M, Akinyelure OP, Kanter J, Ojesina AI.
PMID: 34486556
J Pediatr Hematol Oncol. 2021 Sep 06; doi: 10.1097/MPH.0000000000002296. Epub 2021 Sep 06.

Reduced growth and delayed maturation have been described in children with sickle cell disease (SCD). This study investigated growth and hemolysis in children with SCD in the DISPLACE (Dissemination and Implementation of Stroke Prevention Looking at the Care Environment)...

Cite
Galadanci NA, Sohail M, Akinyelure OP, et al. Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort. J Pediatr Hematol Oncol. 2021;doi: 10.1097/MPH.0000000000002296.
Galadanci, N. A., Sohail, M., Akinyelure, O. P., Kanter, J., & Ojesina, A. I. (2021). Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort. Journal of pediatric hematology/oncology, . https://doi.org/10.1097/MPH.0000000000002296
Galadanci, Najibah A, et al. "Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort." Journal of pediatric hematology/oncology vol. (2021). doi: https://doi.org/10.1097/MPH.0000000000002296
Galadanci NA, Sohail M, Akinyelure OP, Kanter J, Ojesina AI. Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort. J Pediatr Hematol Oncol. 2021 Sep 06; doi: 10.1097/MPH.0000000000002296. Epub 2021 Sep 06. PMID: 34486556.
Copy Download .nbib Format: NLM
Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.

Cancer medicine

Behring M, Ye Y, Elkholy A, Bajpai P, Agarwal S, Kim HG, Ojesina AI, Wiener HW, Manne U, Shrestha S, Vazquez AI.
PMID: 34189853
Cancer Med. 2021 Aug;10(16):5712-5720. doi: 10.1002/cam4.4095. Epub 2021 Jun 29.

BACKGROUND: In silico deconvolution of invasive immune cell infiltration in bulk breast tumors helps characterize immunophenotype, expands treatment options, and influences survival endpoints. In this study, we identify the differential expression (DE) of the LM22 signature to classify immune-rich...

Cite
Behring M, Ye Y, Elkholy A, et al. Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent. Cancer Med. 2021;10(16):5712-5720doi: 10.1002/cam4.4095.
Behring, M., Ye, Y., Elkholy, A., Bajpai, P., Agarwal, S., Kim, H. G., Ojesina, A. I., Wiener, H. W., Manne, U., Shrestha, S., & Vazquez, A. I. (2021). Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent. Cancer medicine, 10(16), 5712-5720. https://doi.org/10.1002/cam4.4095
Behring, Michael, et al. "Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent." Cancer medicine vol. 10,16 (2021): 5712-5720. doi: https://doi.org/10.1002/cam4.4095
Behring M, Ye Y, Elkholy A, Bajpai P, Agarwal S, Kim HG, Ojesina AI, Wiener HW, Manne U, Shrestha S, Vazquez AI. Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent. Cancer Med. 2021 Aug;10(16):5712-5720. doi: 10.1002/cam4.4095. Epub 2021 Jun 29. PMID: 34189853; PMCID: PMC8366080.
Copy Download .nbib Format: NLM
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

British journal of cancer

Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C.
PMID: 33723390
Br J Cancer. 2021 May;124(10):1690-1698. doi: 10.1038/s41416-021-01305-0. Epub 2021 Mar 15.

BACKGROUND: Advanced cervical cancer carries a particularly poor prognosis, and few treatment options exist. Identification of effective molecular markers is vital to improve the individualisation of treatment. We investigated transcriptional data from cervical carcinomas related to patient survival and...

Cite
Halle MK, Sødal M, Forsse D, et al. A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. Br J Cancer. 2021;124(10):1690-1698doi: 10.1038/s41416-021-01305-0.
Halle, M. K., Sødal, M., Forsse, D., Engerud, H., Woie, K., Lura, N. G., Wagner-Larsen, K. S., Trovik, J., Bertelsen, B. I., Haldorsen, I. S., Ojesina, A. I., & Krakstad, C. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. British journal of cancer, 124(10), 1690-1698. https://doi.org/10.1038/s41416-021-01305-0
Halle, Mari K, et al. "A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease." British journal of cancer vol. 124,10 (2021): 1690-1698. doi: https://doi.org/10.1038/s41416-021-01305-0
Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C. A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. Br J Cancer. 2021 May;124(10):1690-1698. doi: 10.1038/s41416-021-01305-0. Epub 2021 Mar 15. PMID: 33723390; PMCID: PMC8110544.
Copy Download .nbib Format: NLM
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Cell

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP.
PMID: 30096301
Cell. 2018 Aug 09;174(4):1033. doi: 10.1016/j.cell.2018.07.036.

No abstract available.

Cite
Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2018;174(4):1033doi: 10.1016/j.cell.2018.07.036.
Robertson, A. G., Kim, J., Al-Ahmadie, H., Bellmunt, J., Guo, G., Cherniack, A. D., Hinoue, T., Laird, P. W., Hoadley, K. A., Akbani, R., Castro, M. A. A., Gibb, E. A., Kanchi, R. S., Gordenin, D. A., Shukla, S. A., Sanchez-Vega, F., Hansel, D. E., Czerniak, B. A., Reuter, V. E., Su, X., de Sa Carvalho, B., Chagas, V. S., Mungall, K. L., Sadeghi, S., Pedamallu, C. S., Lu, Y., Klimczak, L. J., Zhang, J., Choo, C., Ojesina, A. I., Bullman, S., Leraas, K. M., Lichtenberg, T. M., Wu, C. J., Schultz, N., Getz, G., Meyerson, M., Mills, G. B., McConkey, D. J., Weinstein, J. N., Kwiatkowski, D. J., & Lerner, S. P. (2018). Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell, 174(4), 1033. https://doi.org/10.1016/j.cell.2018.07.036
Robertson, A Gordon, et al. "Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer." Cell vol. 174,4 (2018): 1033. doi: https://doi.org/10.1016/j.cell.2018.07.036
Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2018 Aug 09;174(4):1033. doi: 10.1016/j.cell.2018.07.036. PMID: 30096301; PMCID: PMC6297116.
Copy Download .nbib Format: NLM
The Immune Landscape of Cancer.

Immunity

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.
PMID: 31433971
Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004.

No abstract available.

Cite
Thorsson V, Gibbs DL, Brown SD, et al. The Immune Landscape of Cancer. Immunity. 2019;51(2):411-412doi: 10.1016/j.immuni.2019.08.004.
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T. H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., Ziv, E., Culhane, A. C., Paull, E. O., Sivakumar, I. K. A., Gentles, A. J., Malhotra, R., Farshidfar, F., Colaprico, A., Parker, J. S., Mose, L. E., Vo, N. S., Liu, J., Liu, Y., Rader, J., Dhankani, V., Reynolds, S. M., Bowlby, R., Califano, A., Cherniack, A. D., Anastassiou, D., Bedognetti, D., Mokrab, Y., Newman, A. M., Rao, A., Chen, K., Krasnitz, A., Hu, H., Malta, T. M., Noushmehr, H., Pedamallu, C. S., Bullman, S., Ojesina, A. I., Lamb, A., Zhou, W., Shen, H., Choueiri, T. K., Weinstein, J. N., Guinney, J., Saltz, J., Holt, R. A., Rabkin, C. S., Lazar, A. J., Serody, J. S., Demicco, E. G., Disis, M. L., Vincent, B. G., & Shmulevich, I. (2019). The Immune Landscape of Cancer. Immunity, 51(2), 411-412. https://doi.org/10.1016/j.immuni.2019.08.004
Thorsson, Vésteinn, et al. "The Immune Landscape of Cancer." Immunity vol. 51,2 (2019): 411-412. doi: https://doi.org/10.1016/j.immuni.2019.08.004
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I. The Immune Landscape of Cancer. Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004. PMID: 31433971.
Copy Download .nbib Format: NLM
Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease.

Preventive medicine reports

Sakhuja S, Fowler ME, Ojesina AI.
PMID: 33391980
Prev Med Rep. 2020 Nov 28;21:101263. doi: 10.1016/j.pmedr.2020.101263. eCollection 2021 Mar.

Colorectal cancer (CRC) and cardiovascular diseases (CVD) share several risk factors. We examined the relationships between CRC screening and CVD history by race/ethnicity and sex. Data from 15 states across the United States with high age-adjusted CVD rates from...

Cite
Sakhuja S, Fowler ME, Ojesina AI. Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. Prev Med Rep. 2020;21:101263doi: 10.1016/j.pmedr.2020.101263.
Sakhuja, S., Fowler, M. E., & Ojesina, A. I. (2021). Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. Preventive medicine reports, 21101263. https://doi.org/10.1016/j.pmedr.2020.101263
Sakhuja, Swati, et al. "Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease." Preventive medicine reports vol. 21 (2021): 101263. doi: https://doi.org/10.1016/j.pmedr.2020.101263
Sakhuja S, Fowler ME, Ojesina AI. Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. Prev Med Rep. 2020 Nov 28;21:101263. doi: 10.1016/j.pmedr.2020.101263. eCollection 2021 Mar. PMID: 33391980; PMCID: PMC7773575.
Copy Download .nbib Format: NLM
A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer.

Journal of bioinformatics and genomics

Li Y, Zhang X, Akinyemiju T, Ojesina AI, Szychowski JM, Liu N, Xu B, Yi N.
PMID: 34377946
J Bioinform Genom. 2016 Sep;1(1). doi: 10.18454/jbg.2016.1.1.2. Epub 2016 Sep 15.

MOTIVATION: Many traditional clinical prognostic factors have been known for cancer for years, but usually provide poor survival prediction. Genomic information is more easily available now which offers opportunities to build more accurate prognostic models. The challenge is how...

Cite
Li Y, Zhang X, Akinyemiju T, et al. A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer. J Bioinform Genom. 2016;1(1)doi: 10.18454/jbg.2016.1.1.2.
Li, Y., Zhang, X., Akinyemiju, T., Ojesina, A. I., Szychowski, J. M., Liu, N., Xu, B., & Yi, N. (2016). A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer. Journal of bioinformatics and genomics, 1(1), . https://doi.org/10.18454/jbg.2016.1.1.2
Li, Yan, et al. "A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer." Journal of bioinformatics and genomics vol. 1,1 (2016). doi: https://doi.org/10.18454/jbg.2016.1.1.2
Li Y, Zhang X, Akinyemiju T, Ojesina AI, Szychowski JM, Liu N, Xu B, Yi N. A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer. J Bioinform Genom. 2016 Sep;1(1). doi: 10.18454/jbg.2016.1.1.2. Epub 2016 Sep 15. PMID: 34377946; PMCID: PMC8351588.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries